tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CNTA Stock Latest News

Centessa’s ORX489 Phase 1 Trial: Early Safety Readout to Watch for CNTA Investors
Company AnnouncementsCentessa’s ORX489 Phase 1 Trial: Early Safety Readout to Watch for CNTA Investors
15d ago
CNTA
Centessa initiated with an Outperform at Wolfe Research
PremiumThe Fly
Centessa initiated with an Outperform at Wolfe Research
17d ago
CNTA
Centessa Pharmaceuticals CEO Transition to Advisory Role Finalized
PremiumCompany Announcements
Centessa Pharmaceuticals CEO Transition to Advisory Role Finalized
27d ago
8K
CNTA
Centessa management to meet with Piper Sandler
PremiumThe Fly
Centessa management to meet with Piper Sandler
1M ago
CNTA
Centessa price target raised to $38 from $33 at Truist
PremiumThe Fly
Centessa price target raised to $38 from $33 at Truist
1M ago
CNTA
Expanding Beyond Sleep: Buy Rating on Centessa Pharmaceuticals Driven by Compelling Preclinical Data for Orexin Agonist CNT-9982
PremiumRatingsExpanding Beyond Sleep: Buy Rating on Centessa Pharmaceuticals Driven by Compelling Preclinical Data for Orexin Agonist CNT-9982
2M ago
CNTA
Centessa price target raised to $33 from $30 at Truist
Premium
The Fly
Centessa price target raised to $33 from $30 at Truist
2M ago
CNTA
Centessa price target raised to $38 from $35 at Needham
Premium
The Fly
Centessa price target raised to $38 from $35 at Needham
2M ago
CNTA
3 ‘Strong Buy’ Stocks to Buy Now, 1/1/2026, According to Top Analysts
PremiumMarket News
3 ‘Strong Buy’ Stocks to Buy Now, 1/1/2026, According to Top Analysts
2M ago
MIR
SOC
These Are the Most and Least Likely Biotech Takeover Targets for 2026
PremiumMarket News
These Are the Most and Least Likely Biotech Takeover Targets for 2026
3M ago
LLY
TFC
These 3 Unknown Stocks Can Double, Say Five-Star Analysts – 12/11/2025
PremiumMarket News
These 3 Unknown Stocks Can Double, Say Five-Star Analysts – 12/11/2025
3M ago
CLDX
CNTA
Centessa falls -8.4%
PremiumThe Fly
Centessa falls -8.4%
3M ago
CNTA
Centessa Pharmaceuticals Appoints New CEO Amid Strategic Shift
PremiumCompany AnnouncementsCentessa Pharmaceuticals Appoints New CEO Amid Strategic Shift
3M ago
8K
CNTA
Strategic Leadership and Orexin Program Expansion Boost Centessa Pharmaceuticals’ Growth Potential
Premium
Ratings
Strategic Leadership and Orexin Program Expansion Boost Centessa Pharmaceuticals’ Growth Potential
3M ago
CNTA
Centessa CEO Saurabh Saha to step down, Mario Alberto Accardi to succeed
Premium
The Fly
Centessa CEO Saurabh Saha to step down, Mario Alberto Accardi to succeed
3M ago
CNTA
Centessa assumed with an Outperform at Oppenheimer
PremiumThe Fly
Centessa assumed with an Outperform at Oppenheimer
3M ago
CNTA
Centessa price target raised to $42 from $33 at B. Riley
PremiumThe Fly
Centessa price target raised to $42 from $33 at B. Riley
3M ago
ALKS
CNTA
Centessa Pharmaceuticals Amends Sales Agreement for Flexibility
PremiumCompany Announcements
Centessa Pharmaceuticals Amends Sales Agreement for Flexibility
4M ago
8K
CNTA
Centessa price target raised to $43 from $28 at Guggenheim
PremiumThe Fly
Centessa price target raised to $43 from $28 at Guggenheim
4M ago
ALKS
CNTA
Centessa Pharmaceuticals Announces Underwriting Agreement for ADS Offering
PremiumCompany AnnouncementsCentessa Pharmaceuticals Announces Underwriting Agreement for ADS Offering
4M ago
8K
CNTA
Centessa Pharmaceuticals: Promising Market Position with ORX750’s Superior Efficacy and Potential
Premium
Ratings
Centessa Pharmaceuticals: Promising Market Position with ORX750’s Superior Efficacy and Potential
4M ago
CNTA
Morgan Stanley sees Centessa’s ORX750 as ‘best-in-class’ after competitor data
Premium
The Fly
Morgan Stanley sees Centessa’s ORX750 as ‘best-in-class’ after competitor data
4M ago
ALKS
CNTA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >